Skip navigation

Strategies to Effectively Scale the Business and Best Practices for Accounting and Reporting

September 27-28, 2017
  • New Brunswick, NJ

Nancy Aubrey
Partner
RSM US LLP

Chip Baird
Chief Financial Officer
Amicus Therapeutics

Ana Bowman
Controller
Omeros Corporation

Richard Capasso
Executive Director
Ernst & Young LLP

Rhonda Chicko
Vice President, Finance
Editas Medicine

Matt Coffland
Partner
RSM US LLP

Gina Consylman
Vice President of Finance and Chief Accounting Officer
Ironwood Pharmaceuticals

John C. Deighan
Chief Financial Officer
Exeltis USA

Ryan Dolan
Managing Director
CFGI

Jonathan Freve
Chief Financial Officer
Spring Bank Pharmaceuticals, Inc.

Brian Filippini
President
Concord Management Group Int'l

John Green
Corporate Controller, Principal Accounting Officer and Treasurer
Merrimack Pharmaceuticals

Mark Guerin
Chief Financial Officer
Onconova Therapeutics, Inc.

Thomas P. Hess
Senior Vice President and Chief Financial Officer
Genomind

Bill Kracunas
National Leader, Management Consulting
RSM US LLP

John Lanza
National Life Sciences Industry Leader
RSM US LLP

Dave Lewin
Managing Director, Accounting Advisory Practice
CBIZ Tofias

Peter Licata
Chief Financial Officer
Edenbridge Pharmaceuticals

Dave Lowrance
Chief Financial Officer
Savara

Kelly MacDonald
Director, Commercial Finance and Technical Accounting
Ironwood Pharmaceuticals

Federica “Freddi” O’Brien
Chief Financial Officer
Complexa, Inc.

Jason Pitofsky
Executive Director, Financial Reporting
Regeneron Pharmaceuticals

Jim Quinlan
Partner
CFGI

Stephen Rivera
Vice President, Global Technical Accounting Advisory Services & Policy
Johnson & Johnson

William Roberts
Partner
Ernst & Young LLP

Rick Shriner
Principal
RSM US LLP

Ryan J. Udell
Partner and Co-Chair, Corporate Securities Practice
White and Williams LLP

Nancy Aubrey
Partner
RSM US LLP

Chip Baird
Chief Financial Officer
Amicus Therapeutics

Ana Bowman
Controller
Omeros Corporation

Richard Capasso
Executive Director
Ernst & Young LLP

Rhonda Chicko
Vice President, Finance
Editas Medicine

Matt Coffland
Partner
RSM US LLP

Gina Consylman
Vice President of Finance and Chief Accounting Officer
Ironwood Pharmaceuticals

John C. Deighan
Chief Financial Officer
Exeltis USA

Ryan Dolan
Managing Director
CFGI

Jonathan Freve
Chief Financial Officer
Spring Bank Pharmaceuticals, Inc.

Brian Filippini
President
Concord Management Group Int'l

John Green
Corporate Controller, Principal Accounting Officer and Treasurer
Merrimack Pharmaceuticals

Mark Guerin
Chief Financial Officer
Onconova Therapeutics, Inc.

Thomas P. Hess
Senior Vice President and Chief Financial Officer
Genomind

Bill Kracunas
National Leader, Management Consulting
RSM US LLP

John Lanza
National Life Sciences Industry Leader
RSM US LLP

Dave Lewin
Managing Director, Accounting Advisory Practice
CBIZ Tofias

Peter Licata
Chief Financial Officer
Edenbridge Pharmaceuticals

Dave Lowrance
Chief Financial Officer
Savara

Kelly MacDonald
Director, Commercial Finance and Technical Accounting
Ironwood Pharmaceuticals

Federica “Freddi” O’Brien
Chief Financial Officer
Complexa, Inc.

Jason Pitofsky
Executive Director, Financial Reporting
Regeneron Pharmaceuticals

Jim Quinlan
Partner
CFGI

Stephen Rivera
Vice President, Global Technical Accounting Advisory Services & Policy
Johnson & Johnson

William Roberts
Partner
Ernst & Young LLP

Rick Shriner
Principal
RSM US LLP

Ryan J. Udell
Partner and Co-Chair, Corporate Securities Practice
White and Williams LLP